Abruptly switching medications without guidance increases the risk of cardiovascular complications or rebound appetite
Because of its strong effect on both blood sugar and body weight, many doctors are prescribing tirzepatide more often
Thats 44 pounds in a 200 pound person
GLP-3 is NOT FDA approved yet
If you're close to deciding, start with the pricing section (there's a step-up from month one to month two that most people miss), the refund policy (narrower than you'd expect), and the FDA context (June 2026 enforcement activity changes the calculus for anyone starting a compounded program right now)
Recipient shall have no right to modify, derivatize or otherwise create variations of the nucleotide sequence of any proprietary gene, including but not limited to luciferase, NanoBiT technology (e.g., HiBiT), HaloTag technology or genes stably transfected within the cells